| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/10/2007 | CA2322045C Aerosolized active agent delivery |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/10/2007 | CA2245506C Granules from triazines |
| 07/10/2007 | CA2220485C Electrostatic coating |
| 07/10/2007 | CA2203129C Creating an aerosolized formulation of insulin |
| 07/10/2007 | CA2194462C Hard tissue stimulating agent |
| 07/10/2007 | CA2190807C Acetylsalicylic acid and tocopherol stable pharmaceutical composition |
| 07/10/2007 | CA2184461C A method for inhibiting an irregular binding of human lens cells |
| 07/10/2007 | CA2161652C Topical compositions for re-epitheliazation of persistent epithelial defects |
| 07/10/2007 | CA2095776C Rapidly dispersable compositions containing polydextrose |
| 07/05/2007 | WO2007076462A2 Sublimable sustained release delivery system and method of making same |
| 07/05/2007 | WO2007076454A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 07/05/2007 | WO2007076448A2 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 07/05/2007 | WO2007076415A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 07/05/2007 | WO2007076358A1 PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| 07/05/2007 | WO2007076328A2 Rna interference mediated inhibition of hepatitis c virus |
| 07/05/2007 | WO2007076315A2 Aerosol canister employing a polymeric film having improved moisture barrier properties |
| 07/05/2007 | WO2007076310A2 Iontophoretic transdermal delivery of nicotine salts |
| 07/05/2007 | WO2007076295A2 Nanoclusters for delivery of therapeutics |
| 07/05/2007 | WO2007076053A2 Stable s-nitrosothiol formulations |
| 07/05/2007 | WO2007075794A2 Oral formulations comprising tigecycline |
| 07/05/2007 | WO2007075607A1 Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants |
| 07/05/2007 | WO2007075502A2 Thermo-responsive block co-polymers, and use thereof |
| 07/05/2007 | WO2007075475A2 Gastric reflux resistant dosage forms |
| 07/05/2007 | WO2007075447A2 Compositions and methods for oxalate reduction |
| 07/05/2007 | WO2007075408A2 Effervescent compositions for triptans |
| 07/05/2007 | WO2007075381A2 Pharmaceutical compositions of ilaprazole |
| 07/05/2007 | WO2007075252A1 Multilayered chromonic structures |
| 07/05/2007 | WO2007075171A1 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 07/05/2007 | WO2007075142A1 Long term weight maintenance |
| 07/05/2007 | WO2007075120A1 Method for producing a stable aqueous solution of a product containing active substances and a product (variants) |
| 07/05/2007 | WO2007075118A1 Method for producing polyelectrolytic microparticles which contain an encapsulated substance and are sensitive to the environment composition change |
| 07/05/2007 | WO2007074910A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074909A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074904A1 Aqueous pharmaceutical composition |
| 07/05/2007 | WO2007074880A1 Antibody-containing stabilizing preparation |
| 07/05/2007 | WO2007074856A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | WO2007074749A1 Prophylactic and/or therapeutic agent for chronic obstructive pulmonary disease |
| 07/05/2007 | WO2007074641A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 07/05/2007 | WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance |
| 07/05/2007 | WO2007074472A2 Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide |
| 07/05/2007 | WO2007074288A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof |
| 07/05/2007 | WO2007074110A1 Oral formulation of anhydrous olanzapine form i |
| 07/05/2007 | WO2007074043A1 Method for producing vitamin e-adsorbates |
| 07/05/2007 | WO2007073911A2 Masking the taste of powders |
| 07/05/2007 | WO2007073782A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | WO2007073749A1 Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same |
| 07/05/2007 | WO2007073704A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/05/2007 | WO2007073682A1 Dropping pill of butylbenzene phthalein and its application |
| 07/05/2007 | WO2007073646A1 The application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation, chemotherapy sensitization |
| 07/05/2007 | WO2007073643A1 Ultrasonic coupling agent and its preparation process and packaging container contg.same |
| 07/05/2007 | WO2007073596A1 Degradable polymeric microsphere composition |
| 07/05/2007 | WO2007056570A3 Levodopa compositions |
| 07/05/2007 | WO2007056105A3 Human growth hormone patch formulations |
| 07/05/2007 | WO2007054182A3 Nanoparticles used as contrasting agents in magnetic resonance imaging |
| 07/05/2007 | WO2007050711A3 Composition containing alkylene oxide derivative of pectin |
| 07/05/2007 | WO2007048820A3 Micronised azodicarbonamide, the preparation and use thereof |
| 07/05/2007 | WO2007048764A3 Propellant for dosing aerosols comprising packagings |
| 07/05/2007 | WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 07/05/2007 | WO2007024810A3 Compositions and methods for the treatment of wounds and the reduction of scar formation |
| 07/05/2007 | WO2007023495A3 Method for production of single- and multi-layer microcapsules |
| 07/05/2007 | WO2007008566A3 Inorganic shell-based radionuclide nanoparticles bound to biomolecules |
| 07/05/2007 | WO2006135723A3 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 07/05/2007 | WO2006131790A3 Oral ribavirin pharmaceutical composition |
| 07/05/2007 | WO2006130788A3 Dustless powder materials |
| 07/05/2007 | WO2006123285A3 Dispersible bosertan tablet |
| 07/05/2007 | WO2006110862A3 Micelle composition of polymer and passenger drug |
| 07/05/2007 | WO2006059141A8 Protein delivery system |
| 07/05/2007 | WO2005081742A3 Testosterone oral dosage formulations and associated methods |
| 07/05/2007 | US20070155906 Biodegradable multi-block co-polymers |
| 07/05/2007 | US20070155780 Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide |
| 07/05/2007 | US20070155774 Oral formulations of desoxypeganine and thereof uses |
| 07/05/2007 | US20070155768 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 07/05/2007 | US20070155697 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 07/05/2007 | US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 07/05/2007 | US20070155664 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 07/05/2007 | US20070155654 Novel formulations |
| 07/05/2007 | US20070155653 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture containing preservative, surfactant and stabilizer |
| 07/05/2007 | US20070155652 Composition for regenerative treatment of cartilage disease |
| 07/05/2007 | US20070154577 Herbal compositions inhibiting free radicals |
| 07/05/2007 | US20070154566 Method for preparing therapeutic agent for cancer |
| 07/05/2007 | US20070154562 Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof |
| 07/05/2007 | US20070154561 Metal oxide particle and its uses |
| 07/05/2007 | US20070154560 Process for producing microsphere and apparatus for producing the same |
| 07/05/2007 | US20070154559 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate |
| 07/05/2007 | US20070154558 Gelled biopolymer based foam |
| 07/05/2007 | US20070154557 Particulate comprising phytosterols and food compositions comprising said creamer |
| 07/05/2007 | US20070154556 Injectable gel-type bone-repairing material and preparing method thereof |
| 07/05/2007 | US20070154555 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
| 07/05/2007 | US20070154554 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 07/05/2007 | US20070154553 also contains a pharmacologically active substance and a stimulus-responsive compound comprising an azobenzene group or a stilbene group |
| 07/05/2007 | US20070154552 Biologically active native biomatrix composition |
| 07/05/2007 | US20070154551 Coating method |
| 07/05/2007 | US20070154550 Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| 07/05/2007 | US20070154549 Multiparticulate formulations for oral delivery |
| 07/05/2007 | US20070154548 Controlled release metformin formulations |
| 07/05/2007 | US20070154547 Gastric release pulse system for drug delivery |
| 07/05/2007 | US20070154546 Sustained release pharmaceutical compositions |
| 07/05/2007 | US20070154545 Dry formulations of aripiprazole |
| 07/05/2007 | US20070154544 Wet formulations of aripiprazole |